Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Cell Migration through Invadopodia

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hypoxia-inducible factor 1-alpha: a dual regulator of ferroptosis in ischemic stroke and a promising therapeutic target.

Frontiers in neurology·2026

Same author

A Denoising Adversarial Model Based on Hyperellipsoidal Knowledge Representation Learning for DTI Prediction.

IEEE transactions on computational biology and bioinformatics·2026

Same author

Association between frailty status and osteomyelitis: A nested case-control study.

PloS one·2026

Same author

Indium-Mediated Glue-Like Interlayer Enables Stable High-Capacity Flexible Sodium Metal Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

Efficacy of Adding Intravenous Methylprednisolone to Nebulized Budesonide in RSV Pneumonia: Modification by Bacterial Co-Infection - A Retrospective Cohort Study.

Pediatric health, medicine and therapeutics·2026

Same author

Long-term preservation strategy for legume root nodule phenotypes coupled with a comprehensive evaluation method.

BMC plant biology·2026

Search research articles

Related Experiment Video

Updated: Oct 31, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

Potassium Channel Protein KCNK6 Promotes Breast Cancer Cell Proliferation, Invasion, and Migration.

Xiangchan Hou^1,2, Le Tang², Xiayu Li³

¹NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

Frontiers in Cell and Developmental Biology

|July 1, 2021

Summary

Potassium channel KCNK6 is overexpressed in breast cancer, promoting tumor cell proliferation, invasion, and migration. Targeting KCNK6 presents a novel therapeutic strategy for breast cancer treatment.

Keywords:

KCNK6 breast cancer invasion migration potassium channel proliferation

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

Related Experiment Videos

Last Updated: Oct 31, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

Area of Science:

Oncology
Molecular Biology
Biophysics

Background:

Breast cancer incidence is rising globally, necessitating novel therapeutic targets.
Identifying genes driving tumor development is crucial for effective treatment strategies.

Purpose of the Study:

To investigate the role of potassium channel subfamily K member 6 (KCNK6) in breast cancer.
To explore KCNK6 as a potential therapeutic target for breast cancer.

Main Methods:

Analysis of KCNK6 expression in breast cancer tissues.
Assessment of KCNK6's impact on breast cancer cell proliferation, invasion, and migration.
Evaluation of KCNK6's effect on cell adhesion and hardness.

Main Results:

KCNK6 is significantly overexpressed in breast cancer biopsies.
Overexpressed KCNK6 enhances breast cancer cell proliferation, invasion, and migration.
KCNK6 overexpression weakens cell adhesion and reduces cell hardness, contributing to malignancy.

Conclusions:

KCNK6 overexpression promotes breast cancer progression by enhancing cell proliferation, invasion, and migration.
Targeting KCNK6, an ion channel, offers a potential novel therapeutic strategy for breast cancer.